Chemi-Verse™ TTBK2 Kinase Assay Kit

Catalog #
82225
$535 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The Chemi-Verse™ TTBK2 Kinase Assay Kit is designed to measure TTBK2 (tau tubulin kinase 2) serine-threonine kinase activity for screening and profiling applications using ADP-Glo™ as a detection reagent. The assay kit comes in a convenient 96-well format, with enough purified recombinant TTBK2 kinase, kinase substrate, ATP, and kinase assay buffer for 100 enzyme reactions.

Synonyms
Tau-tubulin kinase 2, TTBK2, KIAA0847
Product Info
Storage and Usage
Citations
Assay Kit Format
Luminescent
Materials Required But Not Supplied
  • ADP-Glo™ Kinase Assay (Promega #V6930)
  • DTT (Dithiothreitol), 1M, optional
  • Microplate reader capable of reading luminescence
  • Adjustable micropipettor and sterile tips
  • 30°C incubator
Format
Catalog # Name Amount Storage
  TTBK2* 1.25 µg -80°C
79334 5x Kinase Assay Buffer 1 1.5 ml -20°C
79686 500 µM ATP 50 µl -20°C
78514 Myelin basic protein (MBP), 5 mg/ml 100 µl -20°C
79696 White 96-well plate 1 Room Temp

*The concentration of the protein is lot-specific and will be indicated on the tube.

UniProt #
Q6IQ55
Background

TTBK2, or tau tubulin kinase 2, belongs to the serine-threonine kinase family, involved in primary cilium assembly. Mutations in TTBK2 are responsible for spinocerebellar ataxia 11 (SCA11), which is characterized by loss of Purkinje cells and connection to other neurons in the cerebellum. Loss of TTBK2 in a conditional knockout identified the critical role of this protein in Purkinje cells, where lack of cilia resulted in abnormal intracellular calcium levels and in loss of VGLUT2 positive synapses from dendrites. Studies into the mechanism of action of TTBK2 have identified that mutant protein can interfere with peroxisome numbers and localization, impairing the traffic of SMO (smoothened) to the cilia. Further studies are required to identify the exact functions of this protein and how best to target it when impaired.

References

Bowie E. and Goetz S., 2020 eLife 9: e51166.
Munoz-Estrada J, et al., 2023 bioRxiv: 2023.01.31.526333.